Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;51(2):284-287.
doi: 10.1111/imj.15190.

Managing COVID-19 in patients with inflammatory bowel disease: navigating unprecedented challenges

Ralley E Prentice  1 , Aysha Al-Ani  1 , Britt Christensen  1
Affiliations

Managing COVID-19 in patients with inflammatory bowel disease: navigating unprecedented challenges

Ralley E Prentice et al. Intern Med J. 2021 Feb.

Abstract

The COVID-19 pandemic has demanded a rapid adaptation in healthcare provision, including patients with inflammatory bowel disease (IBD). This viewpoint discusses some of the unique challenges in managing comorbid IBD and COVID-10 experienced by our team at The Royal Melbourne Hospital, which was at the epicentre of the COVID-19 'second-wave' surge in Melbourne.

Keywords: COVID-19; immunosuppression; inflammatory bowel disease.

PubMed Disclaimer

References

    1. Brenner E, Ungaro R, Colombel J, Kappelman M. SECURE‐IBD database public data Update. 2020. [cited 2020 Dec 22]. Available from URL: covidibd.org.
    1. Siegel CA, Christensen B, Kornbluth A, Rosh JR, Kappelman MD, Ungaro RC et al. Guidance for restarting inflammatory bowel disease therapy in patients who withheld immunosuppressant medications during COVID‐19. J Crohns Colitis 2020; 14(Suppl 3): S769–73. - PMC - PubMed
    1. Allez M, Fleshner P, Gearry R, Lakatos PL, Rubin DT. Care of the patient with IBD requiring hospitalization during the COVID‐19 pandemic. J Crohns Colitis 2020; 14: S774–9. - PMC - PubMed
    1. Rubin DT, Abreu MT, Rai V, Siegel CA, International Organization for the Study of Inflammatory Bowel Disease . Management of patients with Crohn's disease and ulcerative colitis during the coronavirus disease‐2019 pandemic: results of an international meeting. Gastroenterology 2020; 159: 6–13.e6. - PMC - PubMed
    1. Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous‐Hunt M, Lewis JD et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID‐19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology 2020; 159: 481.e3–91.e3. - PMC - PubMed